DEEPZEMA AI-AUGMENTED DRUG DISCOVERY Trademark

Trademark Overview


On Tuesday, February 23, 2021, a trademark application was filed for DEEPZEMA AI-AUGMENTED DRUG DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark a serial number of 79308937. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Innovo Therapeutics Inc.. The DEEPZEMA AI-AUGMENTED DRUG DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medicine research; research of pharmaceuticals; drug discovery services; research of crude medicines; research of medicines; research service of pharmaceuticals; development of pharmaceuticals and drugs; clinical trial; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in the field of testing, inspection, research of medical products; conducting early evaluations in the field of new pharmaceuticals; development of biotechnology
deepzema ai-augmented drug discovery

General Information


Serial Number79308937
Word MarkDEEPZEMA AI-AUGMENTED DRUG DISCOVERY
Filing DateTuesday, February 23, 2021
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6720808
Registration DateTuesday, May 24, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements


Description of MarkThe mark consists of the term "DEEPZEMA" in red font above the wording "AI-AUGMENTED DRUG DISCOVERY" in black font. The color white represents background, shading and/or transparent areas and is not claimed as a feature of the mark.
Description of the Colors ClaimedThe color DARK RED appears in the word 'DeepZema', and the color BLACK appears in the word 'AI-augmented Drug Discovery'.
Indication of Colors claimedThe colors dark red and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"DRUG DISCOVERY"
Goods and ServicesMedicine research; research of pharmaceuticals; drug discovery services; research of crude medicines; research of medicines; research service of pharmaceuticals; development of pharmaceuticals and drugs; clinical trial; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in the field of testing, inspection, research of medical products; conducting early evaluations in the field of new pharmaceuticals; development of biotechnology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInnovo Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR

Party NameInnovo Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameInnovo Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Sunday, October 2, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, September 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 9, 2022FINAL DISPOSITION PROCESSED
Wednesday, August 24, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Sunday, February 20, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 2, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021REFUSAL PROCESSED BY IB
Sunday, October 24, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 15, 2021REFUSAL PROCESSED BY MPU
Tuesday, September 28, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 27, 2021NON-FINAL ACTION WRITTEN
Friday, September 17, 2021ASSIGNED TO EXAMINER
Tuesday, April 20, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 15, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB